Total Payments
$7,756
2024 Payments
$1,273
Companies
53
Transactions
527
Medicare Patients
1,759
Medicare Billing
$275,416
Payment Breakdown by Category
Food & Beverage$7,752 (99.9%)
Education$3.90 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,752 | 525 | 99.9% |
| Education | $3.90 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $1,378 | 99 | $0 (2024) |
| ViiV Healthcare Company | $807.05 | 62 | $0 (2024) |
| Merck Sharp & Dohme LLC | $696.50 | 61 | $0 (2024) |
| ABBVIE INC. | $596.73 | 39 | $0 (2024) |
| Amgen Inc. | $417.82 | 32 | $0 (2024) |
| Novo Nordisk Inc | $369.27 | 28 | $0 (2024) |
| Shionogi Inc | $266.53 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $248.78 | 16 | $0 (2024) |
| Esperion Therapeutics, Inc. | $213.72 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $203.98 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,273 | 70 | Gilead Sciences, Inc. ($333.87) |
| 2023 | $1,018 | 56 | Gilead Sciences, Inc. ($199.70) |
| 2022 | $1,259 | 73 | Merck Sharp & Dohme LLC ($166.38) |
| 2021 | $921.58 | 53 | Biohaven Pharmaceuticals, Inc. ($160.02) |
| 2020 | $218.76 | 15 | Amgen Inc. ($41.27) |
| 2019 | $1,120 | 91 | ViiV Healthcare Company ($204.66) |
| 2018 | $858.79 | 70 | Gilead Sciences, Inc. ($162.91) |
| 2017 | $1,087 | 99 | Gilead Sciences Inc ($276.97) |
All Payment Transactions
527 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: VACCINES | ||||||
| 12/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.83 | General |
| 12/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Biological | ||||||
| 12/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.80 | General |
| 11/26/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: ANTIFUNGALS | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/31/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.86 | General |
| 10/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.20 | General |
| 10/25/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: VACCINES | ||||||
| 10/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: VIROLOGY | ||||||
| 10/09/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: HIV | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.31 | General |
| 09/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.85 | General |
| 09/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $2.83 | General |
| 09/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Diabetes Care | ||||||
| 09/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.12 | General |
| 09/04/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: HIV | ||||||
| 09/03/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: VIROLOGY | ||||||
| 08/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.78 | General |
| 08/09/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: VACCINES | ||||||
| 08/08/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: ANTIFUNGALS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 377 | 723 | $218,085 | $55,886 |
| 2022 | 7 | 420 | 834 | $249,488 | $63,820 |
| 2021 | 5 | 436 | 905 | $250,336 | $68,915 |
| 2020 | 5 | 526 | 1,102 | $302,969 | $86,795 |
Total Patients
1,759
Total Services
3,564
Medicare Billing
$275,416
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 97 | 270 | $61,426 | $16,362 | 26.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 117 | 122 | $74,162 | $15,936 | 21.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 78 | 155 | $50,144 | $13,826 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 99 | $30,639 | $9,115 | 29.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 37 | 77 | $1,714 | $646.80 | 37.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 97 | 311 | $96,085 | $23,804 | 24.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 121 | 123 | $71,168 | $17,678 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 117 | $34,467 | $10,268 | 29.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 87 | 180 | $38,956 | $9,691 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $4,939 | $1,455 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $2,153 | $683.79 | 31.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 39 | 81 | $1,720 | $239.88 | 13.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 100 | 304 | $89,570 | $24,010 | 26.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 137 | 139 | $76,781 | $20,696 | 27.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 96 | 226 | $46,228 | $12,419 | 26.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 58 | 127 | $35,557 | $11,464 | 32.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 45 | 109 | $2,200 | $327.00 | 14.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 139 | 420 | $117,376 | $33,827 | 28.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 169 | 175 | $92,515 | $27,275 | 29.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 127 | 302 | $59,336 | $16,891 | 28.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 54 | 120 | $32,109 | $8,549 | 26.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 37 | 85 | $1,633 | $253.44 | 15.5% |
About Dr. Stanley Miller, MD
Dr. Stanley Miller, MD is a Internal Medicine healthcare provider based in Spartanburg, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902851710.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stanley Miller, MD has received a total of $7,756 in payments from pharmaceutical and medical device companies, with $1,273 received in 2024. These payments were reported across 527 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($7,752).
As a Medicare-enrolled provider, Miller has provided services to 1,759 Medicare beneficiaries, totaling 3,564 services with total Medicare billing of $275,416. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location Spartanburg, SC
- Active Since 05/23/2006
- Last Updated 05/18/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1902851710
Products in Payments
- DOVATO (Drug) $387.80
- Mavyret (Drug) $324.09
- Fetroja (Drug) $266.53
- NURTEC ODT (Drug) $240.46
- NEXLETOL (Drug) $213.72
- JARDIANCE (Drug) $192.27
- Ozempic (Drug) $173.03
- DIFICID (Drug) $160.83
- BELSOMRA (Drug) $152.34
- TRIUMEQ (Drug) $151.67
- FARXIGA (Drug) $142.59
- XARELTO (Drug) $141.19
- XIFAXAN (Drug) $137.50
- ZERBAXA (Drug) $135.08
- Vascepa (Drug) $134.89
- JULUCA (Drug) $122.69
- MAVYRET (Drug) $116.68
- Genvoya (Drug) $115.00
- Prolia (Biological) $111.68
- Aimovig (Biological) $110.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Spartanburg
Dr. Vikas Dembla, M.d, M.D
Internal Medicine — Payments: $548,574
Internal Medicine $548,574
Dr. Tondre Buck, M.d, M.D
Internal Medicine — Payments: $390,444
Internal Medicine $390,444
Michael Humeniuk, Md, MD
Internal Medicine — Payments: $28,166
Internal Medicine $28,166
Suzanne Kovacs, Md, MD
Internal Medicine — Payments: $16,168
Internal Medicine $16,168
Dr. Ikenna Onyebueke, Md, MD
Internal Medicine — Payments: $13,555
Internal Medicine $13,555
Dr. Subhashini Subramaniam, Md, MD
Internal Medicine — Payments: $13,395
Internal Medicine $13,395